CVE:KHRN Khiron Life Sciences (KHRN) Stock Price, News & Analysis C$0.04 0.00 (0.00%) As of 05/5/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Khiron Life Sciences Stock (CVE:KHRN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Khiron Life Sciences alerts:Sign Up Key Stats Today's RangeC$0.04▼C$0.0550-Day RangeC$0.04▼C$0.0452-Week RangeC$0.04▼C$0.21Volume24,000 shsAverage Volume256,268 shsMarket CapitalizationC$9.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewKhiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.Read More… Receive KHRN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address KHRN Stock News HeadlinesPharmadrug Stock (OTC:LMLLF), Quotes and News SummaryMay 23, 2024 | benzinga.comFocus: Colombia's cannabis industry in crisis over regulatory, political hurdlesDecember 21, 2023 | msn.comThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?May 24, 2025 | Timothy Sykes (Ad)Global Cannabis Co. Trading Lower On Announcing Amended European Business Sale DealNovember 17, 2023 | benzinga.comKhiron Life Sciences Announces Update to the Proposed Sale of Its European BusinessNovember 16, 2023 | finance.yahoo.comClosing Bell: Khiron Life Sciences Corp WT up on Friday (KHRN-WT)May 24, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp down on Monday (KHRN)May 20, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Tuesday (KHRN-WT)May 4, 2023 | theglobeandmail.comSee More Headlines KHRN Stock Analysis - Frequently Asked Questions How have KHRN shares performed this year? Khiron Life Sciences' stock was trading at C$0.04 at the beginning of 2025. Since then, KHRN shares have increased by 0.0% and is now trading at C$0.04. View the best growth stocks for 2025 here. How do I buy shares of Khiron Life Sciences? Shares of KHRN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Khiron Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Khiron Life Sciences investors own include Khiron Life Sciences (KHRNF), Aurora Cannabis (ACB), Alpha Lithium (APHLF), Curaleaf (CURLF), HEXO (HEXO), Intel (INTC) and Neptune Wellness Solutions (NEPT). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:KHRN CIKN/A Webwww.khiron.ca Phone705-527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-46,800,499.41 Net Margins-258.92% Pretax MarginN/A Return on Equity-68.62% Return on Assets-20.79% Debt Debt-to-Equity Ratio6.68 Current Ratio3.08 Quick Ratio0.72 Sales & Book Value Annual SalesC$18.08 million Price / Sales0.51 Cash FlowC$0.01 per share Price / Cash Flow6.67 Book ValueC$0.20 per share Price / Book0.20Miscellaneous Outstanding Shares232,409,000Free FloatN/AMarket CapC$9.30 million OptionableNot Optionable Beta2.64 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (CVE:KHRN) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Khiron Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.